Quantum BioPharma Statistics
Total Valuation
QNTM has a market cap or net worth of $38.88 million. The enterprise value is $39.21 million.
Important Dates
The last earnings date was Friday, November 7, 2025, before market open.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
QNTM has 3.82 million shares outstanding. The number of shares has increased by 256.09% in one year.
| Current Share Class | 3.82M |
| Shares Outstanding | 3.82M |
| Shares Change (YoY) | +256.09% |
| Shares Change (QoQ) | +25.82% |
| Owned by Insiders (%) | 6.21% |
| Owned by Institutions (%) | 23.31% |
| Float | 3.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.18 |
| P/TBV Ratio | 9.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.34.
| Current Ratio | 1.41 |
| Quick Ratio | 0.60 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -27.66 |
Financial Efficiency
Return on equity (ROE) is -251.26% and return on invested capital (ROIC) is -92.94%.
| Return on Equity (ROE) | -251.26% |
| Return on Assets (ROA) | -72.22% |
| Return on Invested Capital (ROIC) | -92.94% |
| Return on Capital Employed (ROCE) | -255.37% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.68M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +134.58% in the last 52 weeks. The beta is 0.75, so QNTM's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | +134.58% |
| 50-Day Moving Average | 11.89 |
| 200-Day Moving Average | 13.64 |
| Relative Strength Index (RSI) | 51.92 |
| Average Volume (20 Days) | 167,218 |
Short Selling Information
The latest short interest is 32,912, so 0.86% of the outstanding shares have been sold short.
| Short Interest | 32,912 |
| Short Previous Month | 25,073 |
| Short % of Shares Out | 0.86% |
| Short % of Float | 0.92% |
| Short Ratio (days to cover) | 0.28 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -19.17M |
| Pretax Income | -28.71M |
| Net Income | -28.51M |
| EBITDA | -18.64M |
| EBIT | -19.17M |
| Earnings Per Share (EPS) | -$10.10 |
Full Income StatementBalance Sheet
The company has $1.08 million in cash and $2.56 million in debt, giving a net cash position of -$1.47 million or -$0.39 per share.
| Cash & Cash Equivalents | 1.08M |
| Total Debt | 2.56M |
| Net Cash | -1.47M |
| Net Cash Per Share | -$0.39 |
| Equity (Book Value) | 7.51M |
| Book Value Per Share | 2.27 |
| Working Capital | 2.70M |
Full Balance SheetCash Flow
| Operating Cash Flow | -8.77M |
| Capital Expenditures | n/a |
| Free Cash Flow | -8.77M |
| FCF Per Share | -$2.30 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
